Corporate sustainability can be defined as the adoption of practices and policies that integrate environmental, social and economic responsibilities. In health companies in particular, alongside issues related to the minimization of environmental impact, it is essential to analyze the social and governance impacts: to promote a culture about ethical and responsible business practices, social responsibility, diversity and inclusion, protection of human rights.
The first session of 63° Symposium AFI, entitled “Experiences of sustainability in the pharmaceutical world“, is dedicated to these topics: in particular, the meeting will try to analyze which actions and strategies allow us to move, about sustainability, from theory to practice in the pharmaceutical sector and will describe field experiences of green efficiency projects in planning, departments and laboratories.
As it also reminds us, Pierfelice Ferrari, Coordinator of the AFI Energy and Sustainability Study Group, during our interview, in order to implement sustainability in companies it is necessary to adopt some strategies: a shared corporate culture, investments in training (involving top management and all levels) and carry out a constant evaluation of activities and objectives, defining a business plan capable of taking into account all aspects of sustainability (environmental, social and governance).
It is good to remember that, as Ferrari further underlines, the company does not always have control as implementation involves various actors and the complexity of the pharmaceutical sector (as well as its supply chain) represents another critical aspect.
Finally Ferrari introduces us to the monograph that will be presented during the session, describing the objectives.
